Bromocriptine 2.5 mg (Generic)

Product Overview

Bromocriptine 2.5 mg generic tablets are manufactured by Serum Institute India, a company known for producing affordable generic medicines. The product is supplied in strips of ten tablets, with pack options of 30, 60, or 90 tablets. Each strip is sealed to protect against moisture, and the tablets are film‑coated for easy swallowing. Store at room temperature away from direct sunlight. Delivery usually takes six to fifteen days, depending on location and customs. Purchase only from authorized distributors to ensure the medication is genuine and meets regulatory standards. The medication should be kept out of reach of children.

What is Bromocriptine 2.5 mg (Generic)

Bromocriptine is a dopamine‑agonist ergot alkaloid that selectively activates D2 receptors in the hypothalamus and pituitary. The 2.5 mg strength is the standard dose used for hyperprolactinemia, infertility related to elevated prolactin, and as an adjunct in type 2 diabetes. As a generic, it contains the same active ingredient as the reference product but is made by Serum Institute India under Good Manufacturing Practice standards recognized by the FDA. The tablet dissolves quickly in the gut and can be taken with or without food. Batch numbers and expiration dates are printed on each strip for traceability.

Uses and Benefits

Clinically, bromocriptine is used to lower serum prolactin, which can restore regular menstrual cycles and improve ovulation in women with hyperprolactinemia‑related infertility. When added to other antidiabetic regimens, it modestly reduces fasting glucose and helps achieve better post‑prandial control, offering an extra option for patients who have not reached target A1c levels. The drug is also indicated for prolactin‑secreting pituitary adenomas, where it can shrink tumors and relieve symptoms such as galactorrhea. Evidence from MedlinePlus and NIH shows that many patients experience restored ovulation within three to six months and a reduction in glucose excursions when bromocriptine is part of a comprehensive diabetes plan. Improved ovulation can increase the chances of conception when combined with timed intercourse or assisted reproductive techniques.

How It Works

The mechanism of bromocriptine involves binding to D2 receptors in the tuberoinfundibular pathway, which suppresses prolactin secretion from the anterior pituitary. Lower prolactin levels remove inhibition on the hypothalamic‑gonadal axis, allowing ovulation to resume in women with hyperprolactinemia‑related infertility. In type 2 diabetes, bromocriptine influences central pathways that improve insulin sensitivity and reduce hepatic glucose output, effects that are distinct from its antidiabetic dosing in other conditions. Because its action differs from metformin or sulfonylureas, it can be used safely as an add‑on therapy without adding significant hypoglycemia risk.

Dosage Guidelines

Adults are typically prescribed one 2.5 mg tablet taken once daily, preferably in the morning. The tablet may be taken with or without food, as meals do not significantly affect absorption. Patients with moderate renal impairment (eGFR 30‑59 mL/min) should receive 1.25 mg every other day to avoid accumulation. Elderly patients should start at the lowest dose and increase slowly based on tolerance. Treatment length varies: for hyperprolactinemia, therapy may continue for several months, while in diabetes it is often used for a limited period as part of a broader regimen. If a dose is missed, take it as soon as remembered unless it is close to the next scheduled dose; then skip it and resume the regular schedule. Regular laboratory checks of prolactin, liver enzymes, and glucose help guide dose adjustments. Patients should not crush the tablet; it should be swallowed whole with water.

Side Effects

Most adverse events are mild and short‑lived, including nausea, vomiting, abdominal discomfort, dizziness, headache, and constipation. Less common effects include orthostatic hypotension, visual disturbances, and rare hallucinations. Very rare but serious complications such as valvular heart disease may occur with prolonged use; therefore, periodic cardiac evaluation is recommended for long‑term therapy. If any side effect persists beyond two weeks, worsens, or is accompanied by fever, patients should seek medical attention promptly. Dermatologic reactions such as rash or itching are also possible but usually resolve on their own.

Warnings and Precautions

Bromocriptine is contraindicated in patients with known hypersensitivity to the drug or other ergot derivatives, active peptic ulcer disease, or uncontrolled hypertension. Pregnant or breastfeeding women should avoid the medication unless a physician determines that the benefits outweigh potential risks. Patients with severe hepatic cirrhosis may require dose reduction, and concomitant use of certain anti‑migraine agents or antipsychotics can lead to serious interactions. It is essential to disclose all prescription, over‑the‑counter, and herbal products, including St. John’s wort, to the prescribing clinician. Tapering is advised when discontinuing after long‑term treatment to prevent rebound hyperprolactinemia.

Frequently Asked Questions

Q: How soon can ovulation improve? A: Many women notice restored ovulatory cycles within three to six months of consistent therapy, though individual response varies.

Q: Can bromocriptine be taken with insulin or sulfonylureas? A: Yes, but glucose monitoring is essential because the drug may increase insulin sensitivity and raise the risk of hypoglycemia.

Q: Is the 2.5 mg strength suitable for all approved uses? A: The 2.5 mg dose is the standard starting strength for both hyperprolactinemia and as an adjunct in type 2 diabetes; dose adjustments are made based on clinical response.

Q: What should I do if I miss a dose? A: Take the missed tablet as soon as you remember, unless it is near the time of the next dose; then skip it and continue with the regular schedule. Do not double the dose.

Q: Are there any dietary restrictions? A: No specific dietary restrictions are required, but patients should stay well‑hydrated and avoid excessive grapefruit juice, which can affect drug absorption.